1
|
Song Z, Zhang D, Yang L, Zhu P, Liu Y, Wang S, Zheng R. Factor structure and longitudinal invariance for the Chinese Mainland version of the Edinburgh postnatal depression scale during pregnancy. Midwifery 2024; 132:103963. [PMID: 38457994 DOI: 10.1016/j.midw.2024.103963] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/05/2023] [Revised: 02/21/2024] [Accepted: 02/27/2024] [Indexed: 03/10/2024]
Abstract
BACKGROUND There are inconsistent results on the Edinburgh Postnatal Depression Scale's (EPDS) factor structure and longitudinal invariance among different cultures. Furthermore, limited relevant studies in Chinese pregnant women exist. PURPOSE To test the factor structure of the Chinese Mainland EPDS during pregnancy and conduct longitudinal invariance analyses. METHODS A national multi-centre cohort study was conducted among 1207 pregnant women selected consecutively by convenience sampling from five hospitals in Zhuhai, Taiyuan, Haidian, Changchun, and Shenzhen in China between August 2015 and October 2016. Depression was measured by the EPDS during gestational weeks 10-13, 15-18, 23-25, 30-32 and 36-37, respectively.s RESULTS: Three factors with eigenvalues nearly larger than 1.0 were optimal for the Chinese Mainland EPDS, labelled "anxiety," "anhedonia," and "depression," and contained items 3-5, 1-2, and 6-10, respectively. The confirmatory factor analysis results of standardized root mean square residual (SRMR) = 0.034, root mean square error of approximation (RMSEA) = 0.049, comparative fit index (CFI) = 0.968, Tucker-Lewis index (TLI) = 0.954, and χ2, p < 0.05 indicated good fit. For the longitudinal invariance tests, the configural invariance was met, with the CFI and TLI both higher than 0.90 and the RMSEA lower than 0.08 (CFI = 0.919, TLI = 0.908, and RMSEA = 0.034). The metric-, scalar-, and strict invariances were met. CONCLUSIONS The three-factor model of the Chinese Mainland EPDS is invariant in pregnancy, suggesting stability and comparability in identifying the women screened positive at different points during pregnancy and making the scale feasible to screen prenatal depression and anxiety simultaneously.
Collapse
Affiliation(s)
- Zhijiao Song
- Department of Epidemiology, Center of Clinical Epidemiology and Evidence Based Medicine, School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan, Shanxi 030001, China; Department of Health Education, Shanxi Women and Children Health Hospital, Taiyuan 030013, China
| | - Daming Zhang
- Department of Child and Adolescent, School of Public health, Shanxi Medical University, Taiyuan 030001, China; Department of Mental Health, Shanxi Women and Children Health Hospital, Taiyuan 030013, China
| | - Li Yang
- Department of Women's Health, National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, No.12 Dahui Road, Haidian District, Beijing 100081, China
| | - Pengfei Zhu
- Center of Reproductive Medicine, Shanxi Women and Children Health Hospital, Taiyuan, 030013, China
| | - Yan Liu
- Cancer prevention and control office, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan 030013, China
| | - Suping Wang
- Department of Epidemiology, Center of Clinical Epidemiology and Evidence Based Medicine, School of Public Health, Shanxi Medical University, 56 Xinjian South Road, Taiyuan, Shanxi 030001, China.
| | - Ruimin Zheng
- Department of Women's Health, National Center for Women and Children's Health, Chinese Center for Disease Control and Prevention, No.12 Dahui Road, Haidian District, Beijing 100081, China.
| |
Collapse
|
2
|
Deshpande N, Wu M, Kelly C, Woodrick N, Werner DA, Volerman A, Press VG. Video-Based Educational Interventions for Patients With Chronic Illnesses: Systematic Review. J Med Internet Res 2023; 25:e41092. [PMID: 37467015 PMCID: PMC10398560 DOI: 10.2196/41092] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/14/2022] [Revised: 01/30/2023] [Accepted: 03/21/2023] [Indexed: 07/20/2023] Open
Abstract
BACKGROUND With rising time constraints, health care professionals increasingly depend on technology to provide health advice and teach patients how to manage chronic disease. The effectiveness of video-based tools in improving knowledge, health behaviors, disease severity, and health care use for patients with major chronic illnesses is not well understood. OBJECTIVE The aim of this study was to assess the current literature regarding the efficacy of video-based educational tools for patients in improving process and outcome measures across several chronic illnesses. METHODS A systematic review was conducted using CINAHL and PubMed with predefined search terms. The search included studies published through October 2021. The eligible studies were intervention studies of video-based self-management patient education for an adult patient population with the following chronic health conditions: asthma, chronic kidney disease, chronic obstructive pulmonary disease, chronic pain syndromes, diabetes, heart failure, HIV infection, hypertension, inflammatory bowel disease, and rheumatologic disorders. The eligible papers underwent full extraction of study characteristics, study design, sample demographics, and results. Bias was assessed with the Cochrane risk-of-bias tools. Summary statistics were synthesized in Stata SE (StataCorp LLC). Data reporting was conducted per the PRISMA (Preferred Reporting Items for Systematic Reviews and Meta-Analyses) checklist. RESULTS Of the 112 studies fully extracted, 59 (52.7%) were deemed eligible for inclusion in this review. The majority of the included papers were superiority randomized controlled trials (RCTs; 39/59, 66%), with fewer pre-post studies (13/59, 22%) and noninferiority RCTs (7/59, 12%). The most represented conditions of interest were obstructive lung disease (18/59, 31%), diabetes (11/59, 19%), and heart failure (9/59, 15%). The plurality (28/59, 47%) of video-based interventions only occurred once and occurred alongside adjunct interventions that included printed materials, in-person counseling, and interactive modules. The most frequently studied outcomes were disease severity, health behavior, and patient knowledge. Video-based tools were the most effective in improving patient knowledge (30/40, 75%). Approximately half reported health behavior (21/38, 56%) and patient self-efficacy (12/23, 52%) outcomes were improved by video-based tools, and a minority of health care use (11/28, 39%) and disease severity (23/69, 33%) outcomes were improved by video-based tools. In total, 48% (22/46) of the superiority and noninferiority RCTs and 54% (7/13) of the pre-post trials had moderate or high risk of bias. CONCLUSIONS There is robust evidence that video-based tools can improve patient knowledge across several chronic illnesses. These tools less consistently improve disease severity and health care use outcomes. Additional study is needed to identify features that maximize the efficacy of video-based interventions for patients across the spectrum of digital competencies to ensure optimized and equitable patient education and outcomes.
Collapse
Affiliation(s)
- Nikita Deshpande
- Pritzker School of Medicine, University of Chicago, Chicago, IL, United States
| | - Meng Wu
- Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, IL, United States
| | - Colleen Kelly
- Department of Pediatrics, Boston Children's Hospital, Boston, MA, United States
| | - Nicole Woodrick
- Corporate Engagement & Strategic Partnerships, Arizona State University, Tempe, AZ, United States
| | - Debra A Werner
- The University of Chicago Library, Chicago, IL, United States
| | - Anna Volerman
- Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, IL, United States
| | - Valerie G Press
- Section of General Internal Medicine, Department of Medicine, University of Chicago, Chicago, IL, United States
| |
Collapse
|
3
|
Gordon M, Sinopoulou V, Ibrahim U, Abdulshafea M, Bracewell K, Akobeng AK. Patient education interventions for the management of inflammatory bowel disease. Cochrane Database Syst Rev 2023; 5:CD013854. [PMID: 37172140 PMCID: PMC10162698 DOI: 10.1002/14651858.cd013854.pub2] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Indexed: 05/14/2023]
Abstract
BACKGROUND Inflammatory bowel disease (IBD) is a life-long condition for which currently there is no cure. Patient educational interventions deliver structured information to their recipients. Evidence suggests patient education can have positive effects in other chronic diseases. OBJECTIVES To identify the different types of educational interventions, how they are delivered, and to determine their effectiveness and safety in people with IBD. SEARCH METHODS On 27 November 2022, we searched CENTRAL, Embase, MEDLINE, ClinicalTrials.gov, and WHO ICTRP with no limitations to language, date, document type, or publication status. Any type of formal or informal educational intervention, lasting for any time, that had content focused directly on knowledge about IBD or skills needed for direct management of IBD or its symptoms was included. Delivery methods included face-to-face or remote educational sessions, workshops, guided study via the use of printed or online materials, the use of mobile applications, or any other method that delivers information to patients. SELECTION CRITERIA All published, unpublished and ongoing randomised control trials (RCTs) that compare educational interventions targeted at people with IBD to any other type of intervention or no intervention. DATA COLLECTION AND ANALYSIS Two review authors independently conducted data extraction and risk of bias assessment of the included studies. We analysed data using Review Manager Web. We expressed dichotomous and continuous outcomes as risk ratios (RRs) and mean differences (MDs) with 95% confidence intervals (CIs). We assessed the certainty of the evidence using GRADE methodology. MAIN RESULTS We included 14 studies with a total of 2708 randomised participants, aged 11 to 75 years. Two studies examined populations who all had ulcerative colitis (UC); the remaining studies examined a mix of IBD patients (UC and Crohn's disease). Studies considered a range of disease activity states. The length of the interventions ranged from 30 minutes to 12 months. Education was provided in the form of in-person workshops/lectures, and remotely via printed materials or multimedia, smartphones and internet learning. Thirteen studies compared patient education interventions plus standard care against standard care alone. The interventions included seminars, information booklets, text messages, e-learning, a multi professional group-based programme, guidebooks, a staff-delivered programme based on an illustrated book, a standardised programme followed by group session, lectures alternating with group therapy, educational sessions based on an IBD guidebook, internet blog access and text messages, a structured education programme, and interactive videos. Risk of bias findings were concerning in all judgement areas across all studies. No single study was free of unclear or high of bias judgements. Reporting of most outcomes in a homogeneous fashion was limited, with quality of life at study end reported most commonly in six of the 14 studies which allowed for meta-analysis, with all other outcomes reported in a more heterogeneous manner that limited wider analysis. Two studies provided data on disease activity. There was no clear difference in disease activity when patient education (n = 277) combined with standard care was compared to standard care (n = 202). Patient education combined with standard care is probably equivalent to standard care in reducing disease activity in patients with IBD (standardised mean difference (SMD) -0.03, 95% CI -0.25 to 0.20), moderate-certainty evidence. Two studies provided continuous data on flare-up/relapse. There was no clear difference for flare-ups or relapse when patient education (n = 515) combined with standard care was compared to standard care (n = 507), as a continuous outcome. Patient education combined with standard care is probably equivalent to standard care in reducing flare-ups or relapse in patients with IBD (MD -0.00, 95% CI -0.06 to 0.05; moderate-certainty evidence). Three studies provided dichotomous data on flare-up/relapse. The evidence is very uncertain on whether patient education combined with standard care (n = 157) is different to standard care (n = 150) in reducing flare-ups or relapse in patients with IBD (RR 0.94, 95% CI 0.41 to 2.18; very low-certainty evidence). Six studies provided data on quality of life. There was no clear difference in quality of life when patient education combined with standard care (n = 721) was compared to standard care (n = 643). Patient education combined with standard care is probably equivalent to standard care in improving quality of life in patients with IBD (SMD 0.08, 95% CI -0.03 to 0.18; moderate-certainty evidence). The included studies did not report major differences on healthcare access. Medication adherence, patient knowledge and change in quality of life showed conflicting results that varied between no major differences and differences in favour of the educational interventions. Only five studies reported on adverse events. Four reported zero total adverse events and one reported one case of breast cancer and two cases of surgery in their interventions groups, and zero adverse events in their control group. Two studies compared delivery methods of patient education, specifically: web-based patient education interventions versus colour-printed books or text messages; and one study compared frequency of patient education, specifically: weekly educational text messages versus once every other week educational text messages. These did not show major differences for disease activity and quality of life. Other outcomes were not reported. AUTHORS' CONCLUSIONS The ways in which patient educational support surrounding IBD may impact on disease outcomes is complex. There is evidence that education added to standard care is probably of no benefit to disease activity or quality of life when compared with standard care, and may be of no benefit for occurrence of relapse when compared with standard care. However, as there was a paucity of specific information regarding the components of education or standard care, the utility of these findings is questionable. Further research on the impact of education on our primary outcomes of disease activity, flare-ups/relapse and quality of life is probably not indicated. However, further research is necessary, which should focus on reporting details of the educational interventions and study outcomes that educational interventions could be directly targeted to address, such as healthcare access and medication adherence. These should be informed by direct engagement with stakeholders and people affected by Crohn's and colitis.
Collapse
Affiliation(s)
- Morris Gordon
- School of Medicine, University of Central Lancashire, Preston, UK
| | | | | | | | | | | |
Collapse
|
4
|
Lawrence Z, Castillo G, Jang J, Zaki T, Tzimas D, Guttentag A, Goodman A, Dikman A, Williams R. Video Consent for Upper Endoscopy and Colonoscopy Improves Patient Comprehension in a Safety-net, Multi-lingual Population. J Immigr Minor Health 2023; 25:350-356. [PMID: 36152235 DOI: 10.1007/s10903-022-01398-6] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Accepted: 08/15/2022] [Indexed: 11/30/2022]
Abstract
The challenges of consenting for procedures are well documented and are compounded when patients have limited English proficiency (LEP). Standardized video consent has been studied, but research in gastroenterology is limited. We created educational videos in English and Spanish covering the elements of traditional consent for colonoscopy and upper endoscopy. All participants underwent traditional verbal consent and a subset viewed the language and procedure specific video. Participants from a multilingual, safety-net hospital patient population were then given a questionnaire to assess their comprehension and satisfaction. Participants who watched the video had higher comprehension scores than those who received traditional verbal consent alone. This difference persisted when data was stratified by language and procedure, and when controlled for educational level and prior procedure. Video consent improves comprehension and satisfaction for endoscopy and may mitigate some of the challenges encountered when consenting patients with LEP.
Collapse
Affiliation(s)
- Zoe Lawrence
- Division of Gastroenterology, NYU Langone Health, New York, NY, 10016, USA.
| | - Gabriel Castillo
- Division of Gastroenterology, NYU Langone Health, New York, NY, 10016, USA
| | - Janice Jang
- Division of Gastroenterology, NYU Langone Health, New York, NY, 10016, USA
| | - Timothy Zaki
- Department of Medicine, The University of Texas Southwestern Medical Center, Dallas, TX, 75390, USA
| | - Demetrios Tzimas
- Department of Gastroenterology, Northwell Health, Huntington, NY, 11743, USA
| | | | - Adam Goodman
- Division of Gastroenterology, NYU Langone Health, New York, NY, 10016, USA
| | - Andrew Dikman
- Division of Gastroenterology, NYU Langone Health, New York, NY, 10016, USA
| | - Renee Williams
- Division of Gastroenterology, NYU Langone Health, New York, NY, 10016, USA
| |
Collapse
|
5
|
Mavragani A, Miyatani Y, Arita E, Chen P, Ito Y, Kayama H, Reiter J, Kobayashi K, Kobayashi T. Reducing Health Anxiety in Patients With Inflammatory Bowel Disease Using Video Testimonials: Pilot Assessment of a Video Intervention. JMIR Form Res 2023; 7:e39945. [PMID: 36757761 PMCID: PMC9951069 DOI: 10.2196/39945] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Revised: 12/27/2022] [Accepted: 12/27/2022] [Indexed: 12/29/2022] Open
Abstract
BACKGROUND Health anxiety has many damaging effects on patients with chronic illness. Physicians are often unable to alleviate concerns related to living with a disease that has an impact on daily life, and unregulated websites can overrepresent extreme anxiety-inducing outcomes. Educational clinician video interventions have shown some success as an acute anxiolytic in health settings. However, little research has evaluated if peer-based video interventions would be a feasible alternative or improvement. OBJECTIVE This pilot study assesses the efficacy of anxiety reduction for patients with Crohn disease (CD) and those with ulcerative colitis (UC) by showing patient testimonial videos during hospital visits. It investigates the degree to which patient testimonials can affect state anxiety, and whether patients are comfortable enough with the technology to share their stories. METHODS Patients with CD (n=51) and those with UC (n=49) were shown testimonial videos of patients with CD during their physician consultations at Kitasato University Kitasato Institute Hospital in Japan. The video testimonials were collected from Dipex Japan, the Japan branch of an international organization specializing in understanding patient experiences. Patients completed a Visual Analogue Scale for Anxiety before and after viewing the videos, a Hospital Anxiety and Depression Scale (HADS) survey before the videos, and satisfaction surveys. Patients receiving infusion therapy participated in the study while receiving treatment to minimize hospital workflow disruption. RESULTS Anxiety reduction, on the Visual Analog Scale for Anxiety, was significant in the entire cohort both when viewed as an ordinal variable (P=.003, t98=1086.5) and as a continuous variable (P=.01, t94=-2.54, 90% CI -3.47 to -0.72). Eighty percent (n=15) of patients with high HADS Anxiety (HADS-A) scores and 71% (n=24) of patients with high starting state anxiety experienced reduced anxiety after watching testimonials. Patients with high state anxiety but low HADS-A scores experienced anxiety reduction (69%, n=16). Forty-two percent (n=100) of patients responded that they would share their stories for future users. When patients with UC received testimonials from patients with CD, 71% (n=49) of patients reported that they were relevant despite differences in condition. CONCLUSIONS Our pilot results suggest that patient testimonial videos can reduce illness-related state anxiety for patients with CD and those with UC, especially in those with higher baseline state anxiety. The success of this study in reducing anxiety and achieving patient involvement suggests that video interventions for reducing anxiety might be a low-cost intervention that could scale to any number of hospitals, suggesting that technology can help scale up efforts to record and share patient testimonials. Future work can establish whether patient testimonials can be helpful in other contexts, such as before major surgeries or when a family member receives a difficult diagnosis.
Collapse
Affiliation(s)
| | - Yusuke Miyatani
- Center for Advanced Inflammatory Bowel Disease Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan
| | - Etsuko Arita
- Medical Psychology Pharmaceutical Education Research Center, School of Pharmacy, Kitasato University, Tokyo, Japan
| | | | | | | | - Jacob Reiter
- Verily Life Sciences, South San Francisco, CA, United States
| | | | - Taku Kobayashi
- Center for Advanced Inflammatory Bowel Disease Research and Treatment, Kitasato University Kitasato Institute Hospital, Tokyo, Japan
| |
Collapse
|
6
|
Navarro-Correal E, Ibarz A, Basagaña-Farres M, Feijoo-Cid M, Espart A, Selva L. Educational Interventions for Newly Diagnosed Patients With Inflammatory Bowel Disease: A Scoping Review. Gastroenterol Nurs 2023; 46:30-40. [PMID: 36706140 DOI: 10.1097/sga.0000000000000688] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 03/08/2022] [Accepted: 07/01/2022] [Indexed: 01/28/2023] Open
Abstract
The latest consensus standards for patients with inflammatory bowel disease published by the European Crohn's and Colitis Organisation conclude that optimizing quality of care in inflammatory bowel disease involves information and education after diagnosis. A scoping review was performed to identify educational interventions in newly diagnosed inflammatory bowel disease patients. A systematic literature search was conducted using five databases and gray literature. Inclusion criteria were studies with at least one group of patients whom were less than 2 years from their initial inflammatory bowel disease diagnosis. The review process initially identified 447 articles, resulting in four relevant studies: three randomized controlled trials and one pre-/post-test. Only one study exclusively included newly diagnosed inflammatory bowel disease patients. All studies included a multidisciplinary assessment and three were based on a group intervention, but none of them was described in enough detail to be replicated. The content was the same for all patients regardless of the time elapsed since diagnosis. Education of newly diagnosed patients does not seem to be a priority given the lack of publications meeting our criteria despite the evidence of their need. Interventions and outcomes are heterogeneous. Interventions did not consider patient needs and suggest that they centered more on the professional than on the patient. More evidence is clearly needed about this topic.
Collapse
Affiliation(s)
- Ester Navarro-Correal
- Ester Navarro-Correal, MSc, MSN, RN, is Nurse, PhD Student Programme on Health, Nurse and Physiotherapy Department at University of Lleida, Lleida, Spain; Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain; Multidisciplinary Nursing Research Group of Vall d'Hebron Research Institute, Barcelona, Spain
- Arantxa Ibarz, MSN, RN, is Nurse, Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- Míriam Basagaña-Farres, BA, is Librarian, Library, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- María Feijoo-Cid, PhD, BA, RN, is Nurse, Nursing Department, Faculty of Medicine, Universitat Autonoma de Barcelona, Bellaterra, Spain
- Anna Espart, PhD, MSc, MSN, RN, is Serra Húnter Lecturer, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Health Care Research Group (GRECS), Lleida Institute for Biomedical Research Dr Pifarré Foundation, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain
- Laia Selva, PhD, MHSc, LLM, MBE, MSc, BSc, is Postdoctoral Researcher, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain; Health Education Research Group (GREpS), Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain
| | - Arantxa Ibarz
- Ester Navarro-Correal, MSc, MSN, RN, is Nurse, PhD Student Programme on Health, Nurse and Physiotherapy Department at University of Lleida, Lleida, Spain; Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain; Multidisciplinary Nursing Research Group of Vall d'Hebron Research Institute, Barcelona, Spain
- Arantxa Ibarz, MSN, RN, is Nurse, Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- Míriam Basagaña-Farres, BA, is Librarian, Library, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- María Feijoo-Cid, PhD, BA, RN, is Nurse, Nursing Department, Faculty of Medicine, Universitat Autonoma de Barcelona, Bellaterra, Spain
- Anna Espart, PhD, MSc, MSN, RN, is Serra Húnter Lecturer, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Health Care Research Group (GRECS), Lleida Institute for Biomedical Research Dr Pifarré Foundation, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain
- Laia Selva, PhD, MHSc, LLM, MBE, MSc, BSc, is Postdoctoral Researcher, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain; Health Education Research Group (GREpS), Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain
| | - Míriam Basagaña-Farres
- Ester Navarro-Correal, MSc, MSN, RN, is Nurse, PhD Student Programme on Health, Nurse and Physiotherapy Department at University of Lleida, Lleida, Spain; Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain; Multidisciplinary Nursing Research Group of Vall d'Hebron Research Institute, Barcelona, Spain
- Arantxa Ibarz, MSN, RN, is Nurse, Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- Míriam Basagaña-Farres, BA, is Librarian, Library, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- María Feijoo-Cid, PhD, BA, RN, is Nurse, Nursing Department, Faculty of Medicine, Universitat Autonoma de Barcelona, Bellaterra, Spain
- Anna Espart, PhD, MSc, MSN, RN, is Serra Húnter Lecturer, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Health Care Research Group (GRECS), Lleida Institute for Biomedical Research Dr Pifarré Foundation, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain
- Laia Selva, PhD, MHSc, LLM, MBE, MSc, BSc, is Postdoctoral Researcher, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain; Health Education Research Group (GREpS), Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain
| | - María Feijoo-Cid
- Ester Navarro-Correal, MSc, MSN, RN, is Nurse, PhD Student Programme on Health, Nurse and Physiotherapy Department at University of Lleida, Lleida, Spain; Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain; Multidisciplinary Nursing Research Group of Vall d'Hebron Research Institute, Barcelona, Spain
- Arantxa Ibarz, MSN, RN, is Nurse, Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- Míriam Basagaña-Farres, BA, is Librarian, Library, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- María Feijoo-Cid, PhD, BA, RN, is Nurse, Nursing Department, Faculty of Medicine, Universitat Autonoma de Barcelona, Bellaterra, Spain
- Anna Espart, PhD, MSc, MSN, RN, is Serra Húnter Lecturer, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Health Care Research Group (GRECS), Lleida Institute for Biomedical Research Dr Pifarré Foundation, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain
- Laia Selva, PhD, MHSc, LLM, MBE, MSc, BSc, is Postdoctoral Researcher, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain; Health Education Research Group (GREpS), Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain
| | - Anna Espart
- Ester Navarro-Correal, MSc, MSN, RN, is Nurse, PhD Student Programme on Health, Nurse and Physiotherapy Department at University of Lleida, Lleida, Spain; Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain; Multidisciplinary Nursing Research Group of Vall d'Hebron Research Institute, Barcelona, Spain
- Arantxa Ibarz, MSN, RN, is Nurse, Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- Míriam Basagaña-Farres, BA, is Librarian, Library, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- María Feijoo-Cid, PhD, BA, RN, is Nurse, Nursing Department, Faculty of Medicine, Universitat Autonoma de Barcelona, Bellaterra, Spain
- Anna Espart, PhD, MSc, MSN, RN, is Serra Húnter Lecturer, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Health Care Research Group (GRECS), Lleida Institute for Biomedical Research Dr Pifarré Foundation, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain
- Laia Selva, PhD, MHSc, LLM, MBE, MSc, BSc, is Postdoctoral Researcher, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain; Health Education Research Group (GREpS), Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain
| | - Laia Selva
- Ester Navarro-Correal, MSc, MSN, RN, is Nurse, PhD Student Programme on Health, Nurse and Physiotherapy Department at University of Lleida, Lleida, Spain; Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain; Multidisciplinary Nursing Research Group of Vall d'Hebron Research Institute, Barcelona, Spain
- Arantxa Ibarz, MSN, RN, is Nurse, Crohn-Colitis Care Unit, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- Míriam Basagaña-Farres, BA, is Librarian, Library, Vall d'Hebron Hospital Universitari, Barcelona, Spain
- María Feijoo-Cid, PhD, BA, RN, is Nurse, Nursing Department, Faculty of Medicine, Universitat Autonoma de Barcelona, Bellaterra, Spain
- Anna Espart, PhD, MSc, MSN, RN, is Serra Húnter Lecturer, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Health Care Research Group (GRECS), Lleida Institute for Biomedical Research Dr Pifarré Foundation, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain
- Laia Selva, PhD, MHSc, LLM, MBE, MSc, BSc, is Postdoctoral Researcher, Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain; Càtedra de Desenvolupament Desenvolupament i Territoris Saludables (DOTS), University of Lleida, Lleida, Spain; Health Education Research Group (GREpS), Department of Nursing and Physiotherapy, University of Lleida, Lleida, Spain
| |
Collapse
|
7
|
Ostromohov G, Fibelman M, Hirsch A, Ron Y, Cohen NA, Kariv R, Deutsch L, Kornblum J, Anbar R, Maharshak N, Fliss-Isakov N. Assessment of patients' understanding of inflammatory bowel diseases: Development and validation of a questionnaire. United European Gastroenterol J 2021; 10:104-114. [PMID: 34939350 PMCID: PMC8830304 DOI: 10.1002/ueg2.12182] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 08/01/2021] [Accepted: 11/02/2021] [Indexed: 12/15/2022] Open
Abstract
Background Educating patients regarding thier inflammatory bowel disease (IBD) is important for their empowerment and disease management. We aimed to develop a questionnaire to evaluate patient understanding and knowledge of IBD. Methods We have developed the Understanding IBD Questionnaires (U‐IBDQ), consisting of multiple‐choice questions in two versions [for Crohn's disease (CD) and ulcerative colitis (UC)]. The questionnaires were tested for content and face validity, readability, responsiveness and reliability. Convergent validity was assessed by correlating the U‐IBDQ score with physician's subjective assessment scores. Discriminant validity was assessed by comparison to healthy controls (HC), patients with chronic gastrointestinal (GI) conditions other than IBD, and to GI nurses. Multivariate analysis was performed to determine factors associated with a high level of disease understanding. Results The study population consisted of IBD patients (n = 106), HC (n = 35), chronic GI disease patients (n = 38) and GI nurses (n = 19). Mean U‐IBDQ score among IBD patients was 56.5 ± 21.9, similar for CD and UC patients (P = 0.941), but significantly higher than that of HC and chronic GI disease patients and lower than that of GI nurses (P < 0.001), supporting its discriminant validity. The U‐IBDQ score correlated with physician's subjective score (r = 0.747, P < 0.001) and was found to be reliable (intra‐class correlation coefficient = 0.867 P < 0.001). Independent factors associated with high U‐IBDQ scores included academic education (OR = 1.21, 95% CI 1.10–1.33, P < 0.001), biologic therapy experience (OR = 1.24, 95% CI 1.01–1.53, P = 0.046), and IBD diagnosis at <21 years of age (OR = 2.97, 95% CI 1.05–8.87, P = 0.050). Conclusions The U‐IBDQ is a validated, reliable and short, self‐reported questionnaire that can be used for assessing understanding of disease pathophysiology and treatment by IBD patients.
Established knowledge on this subject
Inflammatory bowel diseases (IBD) patients' beliefs and knowledge regarding their disease may affect disease management, quality of life and disease‐related psychological health. Therapy‐related disinformation is associated with low adherence to treatment. A standardized and validated tool for assessment of IBD patients' knowledge and understanding of their disease is lacking.
Significant findings of this study
We developed and meticulously validated the understanding of IBD questionnaire, a short questionnaire aimed at measuring understanding of disease pathophysiology and treatment of IBD. Inflammatory bowel diseases‐related knowledge was associated with education level and with younger age at IBD diagnosis.
Collapse
Affiliation(s)
| | - Morin Fibelman
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Internal Medicine "A", Tel Aviv Medical Center, Tel Aviv, Israel
| | - Ayal Hirsch
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Yulia Ron
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Nathaniel Aviv Cohen
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Revital Kariv
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Liat Deutsch
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Jasmine Kornblum
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Ronit Anbar
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Nutrition and Dietetics Department, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Nitsan Maharshak
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| | - Naomi Fliss-Isakov
- Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel.,Department of Gastroenterology and Liver Diseases, Tel Aviv Medical Center, Tel Aviv, Israel
| |
Collapse
|
8
|
Blake KD, Thai C, Falisi A, Chou WYS, Oh A, Jackson D, Gaysynsky A, Hesse BW. Video-Based Interventions for Cancer Control: A Systematic Review. HEALTH EDUCATION & BEHAVIOR 2019; 47:249-257. [PMID: 31701780 DOI: 10.1177/1090198119887210] [Citation(s) in RCA: 6] [Impact Index Per Article: 1.2] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/31/2022]
Abstract
Background. The use of videos for patient and public health education has been widely adopted and well documented in the literature. Aims. To conduct a systematic review of empirical studies that used video-based interventions for cancer prevention and control to document study designs, settings, approaches, targeted cancer sites and behaviors, and outcomes and to identify gaps in research and practice. Method. PubMed, PsychINFO, CINAHL, SCOPUS, and Web of Science were searched for studies published in the 30-year period from 1984 to 2014. Of 1,521 articles identified, duplicates were removed, and titles and abstracts of 779 were examined for eligibility. In all, 315 articles met the inclusion criteria and were coded by three independent coders. Interrater reliability was assessed. Descriptive frequencies and proportions were calculated. Results. Studies evaluating video interventions for cancer prevention and control have increased over time. The majority used randomized controlled trial designs (54%), followed by single-group pre-posttest designs (18%). Most were delivered in health care settings (39%). Detection (30%) and treatment (16%) were the cancer control continuum stages most frequently addressed, with breast cancer (29%) being the most frequently targeted cancer site. The behavior most commonly targeted was screening/early detection (39%). Topics such as caregiving, coping, palliative care, and end of life were rarely addressed. The majority (69%) reported being successful at achieving their stated objectives, though outcomes varied across studies. Conclusions. Video interventions have been widely utilized for cancer prevention and control, with demonstrated successes. Future research should test innovative designs and new delivery platforms and should include underrepresented topics and cancer sites.
Collapse
Affiliation(s)
| | - Chan Thai
- Santa Clara University, Santa Clara, CA, USA
| | | | | | - April Oh
- National Cancer Institute, Bethesda, MD, USA
| | | | | | | |
Collapse
|
9
|
Kamat N, Kedia S, Ghoshal UC, Nehra A, Makharia G, Sood A, Midha V, Gupta V, Choudhuri G, Ahuja V. Effectiveness and safety of adalimumab biosimilar in inflammatory bowel disease: A multicenter study. Indian J Gastroenterol 2019; 38:44-54. [PMID: 30645725 DOI: 10.1007/s12664-018-0922-1] [Citation(s) in RCA: 25] [Impact Index Per Article: 5.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 09/07/2018] [Accepted: 11/27/2018] [Indexed: 02/04/2023]
Abstract
BACKGROUND Adalimumab has emerged as a useful drug for treating patients with Crohn's disease (CD) and ulcerative colitis (UC), not responding to conventional therapy. There is limited data on effectiveness and safety of adalimumab biosimilar in patients with inflammatory bowel disease (IBD). METHODS Patients with IBD who received at least one dose of adalimumab biosimilar from October 2015 to February 2018 were retrospectively included in this multicenter data analysis. Its effectiveness in inducing and maintaining clinical remission at 8, 26, and 52 weeks for CD and UC and safety profile of the drug was studied. RESULTS Seventy patients (49 CD; 21 UC) with a median age of 39 (range 13-73) years, male predominance (64.3%), and median (IQR) disease duration of 72 (33-104) months were included. Adalimumab biosimilar was effective in inducing remission (at 8 weeks) in 46.9% and 52.4% patients with CD and UC, respectively, of whom 32.7% and 33.3% (three fourths of remitters) maintained remission over 1 year, respectively. Twenty (28.6%) patients experienced adverse events; seven (10%) were serious of whom three had developed tuberculosis. CONCLUSIONS Adalimumab biosimilar in usual clinical practice is safe and effective in inducing and maintaining remission in Indian patients with IBD. Steroid-free clinical remission was observed in one third of patients with UC and CD at 1 year of therapy. Graphical Abstract.
Collapse
Affiliation(s)
- Nagesh Kamat
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110 029, India
| | - Saurabh Kedia
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110 029, India
| | - Uday C Ghoshal
- Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India
| | - Abhimanyu Nehra
- Department of Gastroenterology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, 226 014, India
| | - Govind Makharia
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110 029, India
| | - Ajit Sood
- Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, 141 001, India
| | - Vandana Midha
- Department of Gastroenterology, Dayanand Medical College and Hospital, Ludhiana, 141 001, India
| | - Varun Gupta
- Department of Gastroenterology, Fortis Memorial Research Institute, Gurugram, 122 002, India
| | - Gourdas Choudhuri
- Department of Gastroenterology, Fortis Memorial Research Institute, Gurugram, 122 002, India
| | - Vineet Ahuja
- Department of Gastroenterology, All India Institute of Medical Sciences, New Delhi, 110 029, India.
| |
Collapse
|
10
|
Kamat N, Rajan Mallayasamy S, Sharma P, Kamath A, Pai G. Effect of video-assisted patient education on compliance with therapy, quality of life, psychomorbidity, and cost of illness in irritable bowel syndrome. Postgrad Med 2018; 131:60-67. [PMID: 30445893 DOI: 10.1080/00325481.2019.1549458] [Citation(s) in RCA: 4] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/12/2022]
Abstract
OBJECTIVE Patient education is important in irritable bowel syndrome (IBS), but its effects on outcomes have not been studied extensively. METHODS Patients were enrolled and prospectively divided into an interventional and usual care group. Both received standard of care, but the former additionally received video-assisted patient education. Self-administered questionnaires IBS-quality of life (QOL), Beck Anxiety-Depression Inventory II (BAI, BDI), and Hospital Anxiety and Depression Scale (HADS) were administered at baseline, 3 months, and 6 months. Compliance was defined as drug intake of >80% of the prescribed dose. COI included prospective, prevalence-based, societal perspective. RESULTS Of the 107 patients included, 84 [78.5%; male = 66 (78.57%); median age = 44 (range 20-77 years)] completed the follow up. While the median (inter-quartile range; IQR) QOL scores decreased significantly in both the groups (p < 0.001 for either group), the final scores were significantly better in the interventional group [49 (44-52.5) versus 80 (76-103), respectively; p < 0.005]. There was a significant improvement in the BDI; p < 0.001]. However, the rest did not achieve statistical significance. At 6 months, total median (IQR) semi-annual cost per patient was INR 14,639 (8253-17,909) [US $240 (135-294]. CONCLUSION Video-assisted patient education should be a part of the treatment of IBS since it improves the QOL and depression scores.
Collapse
Affiliation(s)
- Nagesh Kamat
- a Department of Gastroenterology and Hepatology , Kasturba Medical College, Manipal Academy of Higher Education (MAHE) , Manipal , India
| | - Surulivel Rajan Mallayasamy
- b Department of Pharmacotherapy , UNTS College of Pharmacy, University of North Texas Health Science Center , Fort Worth , TX , USA.,c Department of Pharmacy Practice , Manipal College of Pharmaceutical Sciences , Manipal , India
| | - Psvn Sharma
- d Department of Psychiatry , Kasturba Medical College , Manipal , India
| | - Asha Kamath
- e Department of Community Medicine , Kasturba Medical College , Manipal , India
| | - Ganesh Pai
- a Department of Gastroenterology and Hepatology , Kasturba Medical College, Manipal Academy of Higher Education (MAHE) , Manipal , India
| |
Collapse
|